Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy and Safety of Azelastine/Fluticasone Nasal Spray in Perennial Allergic Rhinitis
NCT06051786Phase 2Completed
- Sponsor
- Synmosa Biopharma
- Start
- Aug 2020
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of azelastine, fluticasone propionate nasal spray in perennial allergic rhinitis (PAR), sponsored by Synmosa Biopharma. Started Aug 2020; status: completed.
02
Drugs
azelastinefluticasone propionate nasal spray
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT06051786.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06051786.